PCN25 - Obinutuzumab vs. Ibrutinib in the Treatment of Treatment-Naïve Patients with Chronic Lymphocytic Leukemia —A Cost-Comparison Study in Colombia

Autor: Vecino-Ortiz, A, Díaz-Sotelo, OD, Rodríguez, M, Diaz-Toro, YR, Moreno-Silva, NA
Zdroj: In Value in Health October-November 2017 20(9):A875-A875
Databáze: ScienceDirect